Leucine-rich repeat–containing protein 15 (LRRC15) is a cell surface protein that has emerged as a significant biomarker in cancer biology. This protein is minimally expressed in normal healthy tissue ...

Cancer chemotherapy results have been dramatically improved in recent years by the development of molecularly targeted drugs. However, the incidence of drug resistance because of the instability of ...

Pseudoangiomatous stromal hyperplasia tumors are rare. In this retrospective study, we evaluated the clinical, radiologic, and pathologic features of pseudoangiomatous stromal hyperplasia tumors and ...

Dr. Vinayak Venkataraman, medical oncologist and director of Sarcoma Pathways at Dana-Farber Cancer Institute in Boston, ...

Imatinib (Gleevec) showed durable efficacy in advanced gastrointestinal stromal tumors (GIST), with complete response (CR) or complete resection yielding a twofold increase in median survival, ...

Emerging investigational agents may shift the current standard of care for patients with the rare sarcoma known as ...

Gastrointestinal stromal tumors are the most common mesenchymal tumors of the gastrointestinal (GI) tract. It’s a type of cancer that starts in special cells in the wall of the GI tract, called the ...

Cancers are born when the DNA of a cell changes in some specific ways. The DNA or genetic material of a cell is what contains the genes, the code which controls all of the body’s functions and anatomy ...

Positive top-line results from VIBRANT Phase 2 trial of verekitug in CRSwNP reported in September showed statistically ...

Getting the right nutrition can be challenging when you’re living with advanced gastrointestinal stromal tumors, also known as GIST. GIST usually requires surgeries to remove tumors and certain ...

Researchers at the University of Galway have this week revealed the results of a world-first study into how bowel cancer ...

Prevalence of Pathogenic Germline Variants in Patients With Gastric Cancer Ascertained Through Multigene Panel Testing The molecular heterogeneity of endometrial stromal tumors (ESTs) is demonstrated ...